FDA Regulation Services

 Resolution of Import Alert 66-40/41 and Warning Letter issues

 Joint consulting with former FDA inspectors in the U.S.

 FDA Inspection Support during the Notice of Inspection (NOI) phase

 Acting as Importer of Record (IOR) for OTC drugs and cosmetics shipped to the U.S., and managing customs clearance

 DWPE (Detention Without Physical Examination) and on-site support at the Port of Los Angeles

 Code of Federal Regulations training/consulting (21 CFR 700 & 740 for cosmetics, 21 CFR 201 & 330–358 for OTC)